Sort
11,323 grants matching “glioblastoma”
Biochemistry of Brain Tumor Microvessel Development
$380,637Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2003 · NS
Therapeutically relevant targets of Twist1 dimers in glioma
$380,625Robert C Rostomily · University Of Washington · R01 · FY2015 · NS
Therapeutically relevant targets of Twist1 dimers in glioma
$380,625Robert C Rostomily · University Of Washington · R01 · FY2016 · NS
Glioblastoma stem cells therapy
$380,625Bakhos A. Tannous · Massachusetts General Hospital · R01 · FY2016 · NS
Deciphering mechanisms of perivascular tumor cell invasion in glioblastoma
$380,601Joseph H McCarty · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · NS
Statistical Methods and Validation Analyses for the Integration of External Data in Clinical Trials
$380,463Lorenzo Trippa · Dana-Farber Cancer Inst · R01 · FY2022 · LM
The function of the PRMT5 methylosome in MTAP deleted cancers
$380,377William R Sellers · Broad Institute, Inc. · R01 · FY2022 · CA
The function of the PRMT5 methylosome in MTAP deleted cancers
$380,377William R Sellers · Broad Institute, Inc. · R01 · FY2023 · CA
The epigenetic mechanisms of high-grade pediatric glioblastoma
$380,348Zhiguo Zhang · Columbia University Health Sciences · R01 · FY2017 · CA
SUMO1 inhibition compound as a new anticancer drug for glioblastoma therapy
$380,055Chunhai Charlie Hao · Indiana University Indianapolis · R01 · FY2021 · CA
Biomimetic hydrogel niches to study the malignant phenotype of glioblastoma multiforme
$380,006Brendan A. Harley · University Of Illinois At Urbana-Champaign · R01 · FY2017 · CA
Quinolinate-induced immune suppression in glioblastoma
$380,000Prakash Chinnaiyan · William Beaumont Hospital Research Inst · R01 · FY2023 · NS
Quinolinate-induced immune suppression in glioblastoma
$380,000Prakash Chinnaiyan · William Beaumont Hospital Research Inst · R01 · FY2025 · NS
Glioblastoma stem cells therapy
$379,981Bakhos A. Tannous · Massachusetts General Hospital · R01 · FY2010 · NS
CD44 Antagonists in Targeted and Combinational Therapy for Glioblastoma
$379,946Qin Yu · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · CA
CD44 Antagonists in Targeted and Combinational Therapy for Glioblastoma
$379,946Qin Yu · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · CA
Tumor cell and microenvironment changes causing antiangiogenic therapy resistance
$379,887Manish Aghi · University Of California, San Francisco · R01 · FY2019 · NS
Proj 3: Improving Cancer Therapy using Molecular Imaging
$379,779Brian D. Ross · University Of Michigan At Ann Arbor · P50 · FY2009 · CA
Biomimetic hydrogel niches to study the malignant phenotype of glioblastoma multiforme
$379,771Brendan A. Harley · University Of Illinois At Urbana-Champaign · R01 · FY2020 · CA
Interrogation and interpretation of protein kinase signaling dynamics at single-cell resolution
$379,669Min Xue · University Of California Riverside · R35 · FY2022 · GM
Biosynthetic Metabolic Pathway Regulation of Glioma Growth
$379,651Anita Borton Hjelmeland · University Of Alabama At Birmingham · R01 · FY2019 · NS
Reprogramming the tumormicroenvironment to improve immunotherapy of glioblastoma
$379,634Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2025 · CA
Reprogramming the tumormicroenvironment to improve immunotherapy of glioblastoma
$379,634Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2022 · CA
A novel strategy to overcome the P-gp/BCRP drug efflux system at the blood-brain barrier to improve brain uptake of CNS therapeutics
$379,616Bjoern Bauer · University Of Kentucky · R01 · FY2022 · NS
SUMO1 inhibition compound as a new anticancer drug for glioblastoma therapy
$379,607Chunhai Charlie Hao · Indiana University Indianapolis · R01 · FY2020 · CA